Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of IL-31 monoclonal antibodies for reducing pruritus

Use of IL-31 monoclonal antibodies for reducing pruritus

US Patent 10273297 · Granted Apr 30, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025
Methods of selecting, based on polymorphisms, an inflammatory bowel disease subj2025
Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof2024
Optimized anti-TL1A antibodies2022
Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of2022
Methods of treating prurigo nodularis using anti-IL-31RA antibody compositions2022
Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof2022
Methods of diagnosing inflammatory bowel disease through RNASET22021
Methods of treating Crohn's disease or ulcerative colitis by administering inhib2021
Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR2020